EDGAR Filing Documents for 0001193125-23-077981

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:

SEC Accession No. 0001193125-23-077981

Filing Date

2023-03-23

Accepted

2023-03-23 16:48:27

Documents

Effectiveness Date

2023-03-23

Document Format Files

Seq	Description	Document	Type	Size
1	S-3ASR	d488994ds3asr.htm	S-3ASR	418629
2	EX-4.3	d488994dex43.htm	EX-4.3	95231
3	EX-4.4	d488994dex44.htm	EX-4.4	98152
4	EX-5.1	d488994dex51.htm	EX-5.1	27698
5	EX-23.1	d488994dex231.htm	EX-23.1	1689
6	EX-FILING FEES	d488994dexfilingfees.htm	EX-FILING FEES	52582
7	GRAPHIC	g488994dsp095.jpg	GRAPHIC	3048
8	GRAPHIC	g488994g04z35.jpg	GRAPHIC	35178
9	GRAPHIC	g488994g41p62.jpg	GRAPHIC	41560
10	GRAPHIC	g488994g63h54.jpg	GRAPHIC	43055
	Complete submission text file	0001193125-23-077981.txt		852714

Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560

Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800

CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)